- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| NEOLA MEDICAL Aktie jetzt für 0€ handeln | |||||
| 13.11. | Neola Medical AB: Neola Medical granted Patent in China for reducing optical noise in lung monitoring measurements | 76 | GlobeNewswire (Europe) | Neola Medical AB (publ) has been granted its first patent in China for a technical solution that reduces noise in measurements for continuous lung monitoring. The patent protects an innovation designed... ► Artikel lesen | |
| 04.11. | Neola Medical AB Q3 Sales Increase | 4 | RTTNews | ||
| 04.11. | Neola Medical AB: Neola Medical Q3 Report 2025 - Progressing toward completion of Swedish clinical pilot study and strengthening leadership team | 12 | GlobeNewswire (Europe) | During the quarter Neola Medical strengthened the leadership team with appointment of a Clinical Director. In addition, the company's IP portfolio was reinforced in Europe with a newly granted patent... ► Artikel lesen | |
| 04.11. | Neola Medical AB: Revised Timeline Announced as Clinical Pilot Study Indicates Robust Safety and Need for Optimization of Neola | 29 | GlobeNewswire (Europe) | Preliminary results from Neola Medical's ongoing clinical pilot study on preterm born babies indicate a robust safety profile of the medical device Neola®.
The preliminary findings indicate variations... ► Artikel lesen | |
| 16.10. | Neola Medical AB: Neola Medical Strengthens Global IP Portfolio with New Patents Granted in both the U.S. and China for Medical Device Neola | 93 | GlobeNewswire (Europe) | Neola Medical AB (publ) has been granted patents in both the U.S. and China for a technical method that improve the accuracy of continuous lung monitoring with the company's medical device, Neola®.... ► Artikel lesen | |
| 25.09. | Neola Medical AB: Neola Medical strengthens leadership team with appointment of Clinical Director | 102 | GlobeNewswire (Europe) | Neola Medical AB (publ) is pleased to announce the appointment of Eva Bondesson as Clinical Director, effective October 1, 2025. As Neola Medical advances through the clinical phase, Eva Bondesson brings... ► Artikel lesen | |
| 10.09. | Neola Medical AB: Neola Medical granted European patent enabling lung monitoring beyond preterm born babies | 79 | GlobeNewswire (Europe) | Neola Medical AB (publ) announces today that the company has been granted a European patent for an invention aiming to enable lung monitoring in broader patient groups. This new patent complements the... ► Artikel lesen | |
| 25.08. | Neola Medical AB: Neola Medical Q2 Report 2025 - First U.S. Clinical Study Site Agreement Signed, Key Step in Regulatory Path to Market Authorization | 94 | GlobeNewswire (Europe) | Neola Medical advanced its U.S. regulatory pathway in the second quarter of 2025, signing an agreement with Children's Regional Hospital at Cooper and securing IRB approval to enable the initiation... ► Artikel lesen | |
| 21.05. | Neola Medical AB: Neola Medical Q1 Report 2025 - Strengthened shareholder base with institutional investors ahead of clinical study start | 191 | GlobeNewswire (Europe) | The first quarter of 2025 was both strategically and clinically significant for Neola Medical. The company strengthened its financial position through a successful directed share issue of approximately... ► Artikel lesen | |
| 25.03. | Neola Medical AB: Neola Medical Signs Agreement with Södra Älvsborgs Sjukhus in Borås to Initiate Clinical Pilot Study on Preterm Born Babies | 115 | GlobeNewswire (Europe) | Neola Medical is pleased to announce the signing of a contract with Södra Älvsborgs Sjukhus in Borås, to conduct the company's first clinical pilot study on preterm born babies, with its continuous... ► Artikel lesen | |
| 05.03. | Neola Medical AB: Neola Medical Granted New Patent Family in China, Protection for Lung Monitoring | 185 | GlobeNewswire (Europe) | Neola Medical AB has been granted a patent in China that strengthens the protection of the company's fundamental concept of measuring gases in body cavities using gas absorption spectroscopy for continuous... ► Artikel lesen | |
| 12.02. | Neola Medical AB: Neola Medical Q4 Report 2024 - Received approval for initiation of first clinical pilot study on preterm born babies | 183 | GlobeNewswire (Europe) | Neola Medical achieved key milestones in 2024, instrumental to its planned FDA application: securing the CB certificate and successfully completing the Human Factors Validation study. These accomplishments... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 41,770 | +1,16 % | Ihre wichtigsten Termine: Alle Analysten-Augen auf: Siemens Healthineers, Deutsche Bank und Suss Microtec | © Foto: Daniel Karmann/dpa Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 10:00... ► Artikel lesen | |
| FRESENIUS | 46,940 | +0,34 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
17.11.2025 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,540 | +2,32 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 43,360 | +1,98 % | Carl Zeiss Meditec-Aktie mit Aufwärtssignalen - Experten halten große Kursgewinne für möglich! | ||
| GERRESHEIMER | 23,560 | 0,00 % | EQS-News: Gerresheimer AG: Science Based Targets Initiative bestätigt CO2e Reduktionsziele | EQS-News: Gerresheimer AG
/ Schlagwort(e): Nachhaltigkeit
Gerresheimer: Science Based Targets Initiative bestätigt CO2e Reduktionsziele
18.11.2025 / 10:02 CET/CEST
Für... ► Artikel lesen | |
| BETA BIONICS | 31,420 | +10,32 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| UNITEDHEALTH | 277,80 | 0,00 % | UNITEDHEALTH GROUP INC: Jetzt wird's ernst am Markt! | ||
| PROCEPT BIOROBOTICS | 29,830 | +6,96 % | Piper Sandler Reiterates a Buy on PROCEPT BioRobotics Corporation (PRCT) | ||
| MOBILE-HEALTH NETWORK SOLUTIONS | 4,710 | +53,42 % | Mobile-health Network Solutions Signs MOU to Secure Two Malaysian AI Data Center Projects; Facilities Intended to Power Expansion of Company's AI Digital Health Platform | Singapore, Singapore--(Newsfile Corp. - November 21, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI HealthTech platform, today announced the signing... ► Artikel lesen | |
| OTTOBOCK | 70,85 | -2,95 % | ANALYSE-FLASH: Jefferies startet Ottobock mit 'Buy' - Ziel 84 Euro | NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat die Bewertung von Ottobock beim Kursziel von 84 Euro mit "Buy" aufgenommen. Der Rollstuhlspezialist spiele eine globale Führungsrolle im Bereich... ► Artikel lesen | |
| GENEDX | 146,55 | +9,29 % | GeneDx auf der Jefferies London Konferenz: Strategische Expansion in der Pädiatrie | ||
| BRIGHTSPRING HEALTH SERVICES | 34,620 | +5,71 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROGYNY | 25,850 | +4,11 % | Progyny, Inc.: New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action | ||
| ECKERT & ZIEGLER | 15,470 | +0,19 % | BERENBERG stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Eckert & Ziegler auf "Buy" mit einem Kursziel von 24 Euro belassen. Der Strahlen- und Medizintechnikkonzern habe durchwachsene Zahlen vorgelegt... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,700 | +3,95 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen |
Das Unternehmen NEOLA MEDICAL AB kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEOLA MEDICAL AB finden Sie auf Wallstreet Online.